Royalty Pharma (RPRX) Shareholder's Equity (2019 - 2026)
Royalty Pharma (RPRX) Shareholder's Equity (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
502.95 Mn |
| 10 |
Royalty Pharma |
23.13 Bn |
25.57 Bn |
- |
9.94 Bn |
| Date | Value |
|---|
| Mar 31, 2026 |
9.94 Bn |
| Dec 31, 2025 |
9.71 Bn |
| Sep 30, 2025 |
9.62 Bn |
| Jun 30, 2025 |
9.50 Bn |
| Mar 31, 2025 |
9.78 Bn |
| Dec 31, 2024 |
10.34 Bn |
| Sep 30, 2024 |
10.26 Bn |
| Jun 30, 2024 |
9.75 Bn |
| Mar 31, 2024 |
9.86 Bn |
| Dec 31, 2023 |
10.08 Bn |
| Sep 30, 2023 |
9.59 Bn |
| Jun 30, 2023 |
9.81 Bn |
| Mar 31, 2023 |
9.82 Bn |
| Dec 31, 2022 |
9.53 Bn |
| Sep 30, 2022 |
10.42 Bn |
| Jun 30, 2022 |
10.41 Bn |
| Mar 31, 2022 |
10.14 Bn |
| Dec 31, 2021 |
10.25 Bn |
| Sep 30, 2021 |
10.39 Bn |
| Jun 30, 2021 |
10.41 Bn |
